glp 1 drugs origin Discovery of GLP-1–Based for the Treatment of Obesity The Rise of GLP-1 Medications
Description
In addition, Aviles-Olmos 2013 has 6 records [28, 37, 41,42,43,44]
As a result, several post hoc analyses have investigated the risk of developing pancreatitis as a result of DPP-4 inhibitor therapy
Arans C, Edvardsson CE, Shevchouk OT, Zhang Q, Witley S, Blid Skldheden S, et al
The study used electronic health records (EHRs) from the TriNetX US Collaborative Network, covering over 100 million patients
